Antioxidants can increase melanoma metastasis in mice
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Antioxidants increase migration and invasion of human melanoma cells and accelerate metastasis in an endogenous mouse model of malignant melanoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a mouse model with BRAFV600E mutation and PTEN deletion, NAC increased metastasis, but had no effect on primary tumors77.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [77]
In the citing paper
“NAC treatment also increased migration and invasion of melanoma cell lines in vitro by activating RhoA77.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [77]
In the citing paper
“recent results from both human and animal studies have found no clear evidence of the benefit of antioxidant treatment in preventing or suppressing cancer development.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [15]
In the citing paper
“antioxidant treatment even appeared to accelerate cancer progression and metastasis in mouse models of lung adenocarcinoma and melanoma14–16”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [15]
Citations
Cites
1 retracted
Ma, J., Zhang, Q. H., Chen, S., Fang, B., Yang, Q., Chen, C., Miele, L., Sarkar, F. H., Xia, J., & Wang, Z. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069485 · Cited by 71
Retracted(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
The chemistry and antioxidant properties of tocopherols and tocotrienols
Kamal‐Eldin, A., & Appelqvist, L. (1996) · Lipids · doi:10.1007/bf02522884 · Cited by 1,833
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Antioxidants and Prevention of Chronic Disease
WILLCOX, J. K., ASH, S. L., & CATIGNANI, G. L. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490468489 · Cited by 1,188
MITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Cited by
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
“How does the release of chemokines and cytokines help circulating tumor cells? The migration of metastatic cells in circulation often relies on a spectrum of chemokines and complement components that direct tumor cells through the vasculature(208,209) and metabolic factors that result in an antioxidant effect.(210) Gr…”
BackgroundROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,595
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
“Conversely, in the presence of severe oxidative stress, ROS de facto inhibit metastatic dissemination, most likely as a direct consequence of reduced fitness and RCD or cellular senescence [159-161].”
BackgroundThe metabolism of cancer cells during metastasis
Bergers, G., & Fendt, S.-M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00320-2 · Cited by 950
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
Lymph protects metastasizing melanoma cells from ferroptosis
Ubellacker, J. M., Tasdogan, A., Ramesh, V., Shen, B., Mitchell, E. C., Martin-Sandoval, M. S., Gu, Z., McCormick, M. L., Durham, A. B., Spitz, D. R., et al. (2020) · Nature · doi:10.1038/s41586-020-2623-z · Cited by 896
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Lone, S. N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S., El-Rifai, W., Bedognetti, D., Batra, S. K., Haris, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01543-7 · Cited by 819
“Such cellular aggregates are, thus, protected against oxidative stress and the surrounding immune system [13, 14].”
BackgroundROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., & Shi, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0648-1 · Cited by 735
Metabolic programming and immune suppression in the tumor microenvironment
Arner, E. N., & Rathmell, J. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.009 · Cited by 668
Targeting ROS in cancer: rationale and strategies
Glorieux, C., Liu, S., Trachootham, D., & Huang, P. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00979-4 · Cited by 651
“Redox modulation has long been considered a promising strategy for cancer treatment, but conflicting preclinical and clinical results have been observed 5,243,244,262 , suggesting a need to carefully evaluate different experimental models and clinical settings.”
The pentose phosphate pathway in health and disease
TeSlaa, T., Ralser, M., Fan, J., & Rabinowitz, J. D. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00863-2 · Cited by 650
The Complex Interplay between Antioxidants and ROS in Cancer
Harris, I. S., & DeNicola, G. M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.002 · Cited by 626
“Similar to NAC, vitamin E promotes lung tumor andmelanoma growth and progression [82,83].”
BackgroundMechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
The Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Wiel, C., Le Gal, K., Ibrahim, M. X., Jahangir, C. A., Kashif, M., Yao, H., Ziegler, D. V., Xu, X., Ghosh, T., Mondal, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.005 · Cited by 579
Self-citationROS in Cancer: The Burning Question
Chio, I. I. C., & Tuveson, D. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.004 · Cited by 532
“Similar results were obtained in an endogenous oncogenic Braf/PTEN null mouse model of melanoma, where NAC and Trolox increased the rate of melanoma cell migration and invasion without impacting the growth of primary tumors (Le Gal et al., 2015).”
ResultMetabolic heterogeneity confers differences in melanoma metastatic potential
Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1847-2 · Cited by 509
RETRACTED: Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms
Slika, H., Mansour, H., Wehbe, N., Nasser, S. A., Iratni, R., Nasrallah, G., Shaito, A., Ghaddar, T., Kobeissy, F., & Eid, A. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112442 · Cited by 441
RetractedTargeting cancer vulnerabilities with high-dose vitamin C
Ngo, B., Van Riper, J. M., Cantley, L. C., & Yun, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0135-7 · Cited by 423
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Palmirotta, R., Lovero, D., Cafforio, P., Felici, C., Mannavola, F., Pellè, E., Quaresmini, D., Tucci, M., & Silvestris, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918794630 · Cited by 423
Lopez-Gonzalez, R., Lu, Y., Gendron, T. F., Karydas, A., Tran, H., Yang, D., Petrucelli, L., Miller, B. L., Almeida, S., & Gao, F.-B. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.015 · Cited by 419
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Kim, S. J., Kim, H. S., & Seo, Y. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5381692 · Cited by 406
“Indeed, the GSH/GSSG ratio tends to be lower in circulating melanoma or metastatic cancers, suggesting that late-stage cancers have better antioxidant processes than early-stage cancers [62, 63].”
BackgroundEzeriņa, D., Takano, Y., Hanaoka, K., Urano, Y., & Dick, T. P. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.01.011 · Cited by 403
“…numerous insights concerning the involvement of ROS in tumor initiation, progression and metastasis have been obtained with the help of NAC (Irani et al., 1997; Le Gal et al., 2015; Ma et al., 2009; Piskounova et al., 2015; Radisky et al., 2005; Sayin et al., 2014; Schafer et al., 2009).”
BackgroundMechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Metastasis-Initiating Cells and Ecosystems
Massagué, J., & Ganesh, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0010 · Cited by 372
“Elimination of cancer cells after extravasation is driven by passive factors such as high oxidative stress in the lungs (69, 70), a dearth of growth factors and nutrients in the cerebrospinal fluid (38, 71), or, more generally, a lack of the appropriate microenvironment cues that had nursed the growth of MICs in the p…”
BackgroundTargeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 366
Jeong, Y., Hoang, N. T., Lovejoy, A., Stehr, H., Newman, A. M., Gentles, A. J., Kong, W., Truong, D., Martin, S., Chaudhuri, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0127 · Cited by 345
Liu, W., Chakraborty, B., Safi, R., Kazmin, D., Chang, C.-Y., & McDonnell, D. P. (2021) · Nature Communications · doi:10.1038/s41467-021-25354-4 · Cited by 341
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Fendt, S.-M., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 313
Targeting Oxidative Stress in Central Nervous System Disorders
Patel, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.007 · Cited by 312
“For example, a negative impact of antioxidant therapies has been noted on cancer metastasis and progression [1,2].”
BackgroundLim, J. K. M., Delaidelli, A., Minaker, S. W., Zhang, H.-F., Colovic, M., Yang, H., Negri, G. L., von Karstedt, S., Lockwood, W. W., Schaffer, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821323116 · Cited by 308
Weng, Q., Sun, H., Fang, C., Xia, F., Liao, H., Lee, J., Wang, J., Xie, A., Ren, J., Guo, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21714-2 · Cited by 302
Anticancer Properties of Essential Oils and Other Natural Products
Blowman, K., Magalhães, M., Lemos, M. F. L., Cabral, C., & Pires, I. M. (2018) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2018/3149362 · Cited by 296
“Specifically, oxidized glutathione, an indicator of oxidative stress levels, was increased on antioxidant administration, thus offering protection for the melanoma metastasis cancer cells [75].”
BackgroundIppolito, L., Morandi, A., Taddei, M. L., Parri, M., Comito, G., Iscaro, A., Raspollini, M. R., Magherini, F., Rapizzi, E., Masquelier, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0805-7 · Cited by 287
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Wang, H., Liu, X., Long, M., Huang, Y., Zhang, L., Zhang, R., Zheng, Y., Liao, X., Wang, Y., Liao, Q., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6095 · Cited by 286
“Our results support the notion that ROS limit distant metastasis and that antioxidants accelerate migration and invasion of cancer cells (35, 36).”
ResultRho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
Missiroli, S., Perrone, M., Genovese, I., Pinton, P., & Giorgi, C. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102943 · Cited by 251
“Conversely, several studies demonstrated that oxidative stress limits metastatic dissemination in melanoma and lung cancer [17 (cid:1) 19].”
BackgroundCancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
Takahashi, N., Chen, H.-Y., Harris, I. S., Stover, D. G., Selfors, L. M., Bronson, R. T., Deraedt, T., Cichowski, K., Welm, A. L., Mori, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.001 · Cited by 271
Cancer, Oxidative Stress, and Metastasis
Gill, J. G., Piskounova, E., & Morrison, S. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030791 · Cited by 266
Mitophagy in tumorigenesis and metastasis
Poole, L. P., & Macleod, K. F. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03774-1 · Cited by 241
Metabolic Hallmarks of Metastasis Formation
Elia, I., Doglioni, G., & Fendt, S.-M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.002 · Cited by 248
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
Cheung, E. C., DeNicola, G. M., Nixon, C., Blyth, K., Labuschagne, C. F., Tuveson, D. A., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.012 · Cited by 243
Crosstalk between calcium and reactive oxygen species signaling in cancer
Hempel, N., & Trebak, M. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.01.007 · Cited by 239
Hong, X., Roh, W., Sullivan, R. J., Wong, K. H. K., Wittner, B. S., Guo, H., Dubash, T. D., Sade-Feldman, M., Wesley, B., Horwitz, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1500 · Cited by 234
“In an endogenous mouse model of malignant melanoma, in vivo administration of NAC or the vitamin E analogue Trolox accelerates tumor progression and lymph node metastasis (66).”
BackgroundExtracellular Glutathione Peroxidase GPx3 and Its Role in Cancer
Chang, C., Worley, B. L., Phaëton, R., & Hempel, N. (2020) · Cancers · doi:10.3390/cancers12082197 · Cited by 226
“Given that NAC has been shown to promote metastasis of some tumor types [8,141], it is of interest to determine if the presence of GPx3 in the tumor microenvironment is necessary for the pro-metastatic actions of NAC.”
BackgroundSayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231
Self-citationCell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization
Labuschagne, C. F., Cheung, E. C., Blagih, J., Domart, M.-C., & Vousden, K. H. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.014 · Cited by 225
The pleiotropic functions of reactive oxygen species in cancer
Wu, K., El Zowalaty, A. E., Sayin, V. I., & Papagiannakopoulos, T. (2024) · Nature Cancer · doi:10.1038/s43018-024-00738-9 · Cited by 196
“114) and to promote distal and lymph node melanoma metastases 131,132 .”
Self-citationThe Warburg metabolism fuels tumor metastasis
Lu, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09794-5 · Cited by 218
Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship
Schofield, J. H., & Schafer, Z. T. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8058 · Cited by 204
“As discussed above, mtROS can function (in some contexts) as a de facto tumor suppressor (75) as neutralization of ROS can enable tumor progression and metastasis (28, 41, 61, 88, 121).”
Rapamycin for longevity: opinion article
Blagosklonny, M. V. (2019) · Aging · doi:10.18632/aging.102355 · Cited by 205
“Also disturbing is the finding that antioxidants accelerate cancer progression and promote metastasis [134-136].”
BackgroundReactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Sarmiento-Salinas, F. L., Perez-Gonzalez, A., Acosta-Casique, A., Ix-Ballote, A., Diaz, A., Treviño, S., Rosas-Murrieta, N. H., Millán-Perez-Peña, L., & Maycotte, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119942 · Cited by 197
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 219
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Hanley, C. J., Mellone, M., Ford, K., Thirdborough, S. M., Mellows, T., Frampton, S. J., Smith, D. M., Harden, E., Szyndralewiez, C., Bullock, M., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx121 · Cited by 195
“Inhibition of hedgehog signalling and depletion of FAP-positive CAFs have been shown to enhance chemotherapy delivery (49) and antitumor immunity (4) in murine models.”
BackgroundMedical and Dietary Uses of N-Acetylcysteine
Šalamon, Š., Kramar, B., Marolt, T. P., Poljšak, B., & Milisav, I. (2019) · Antioxidants · doi:10.3390/antiox8050111 · Cited by 186
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 170
Roles of reactive oxygen species in inflammation and cancer
Yu, Y., Liu, S., Yang, L., Song, P., Liu, Z., Liu, X., Yan, X., & Dong, Q. (2024) · MedComm · doi:10.1002/mco2.519 · Cited by 164
“141,172 Vitamin E is also recognized as an antitumor supplement.”
BackgroundReactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype
Rodic, S., & Vincent, M. D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31069 · Cited by 181
Cancer drug resistance: redox resetting renders a way
Liu, Y., Li, Q., Zhou, L., Xie, N., Nice, E. C., Zhang, H., Huang, C., & Lei, Y. (2106) · Oncotarget · doi:10.18632/oncotarget.8600 · Cited by 177
“Likewise, a study showed that NAC increased melanoma metastasis in vivo through the small guanosine triphosphatase (GTPase) RHOA activation [153].”
BackgroundZahra, K. F., Lefter, R., Ali, A., Abdellah, E.-C., Trus, C., Ciobica, A., & Timofte, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9965916 · Cited by 167
“The antioxidants and ROS display yet controversial or contradictory roles in tumorigenesis, as ROS which more often are involved in tumor development and progression, are also toxic to cancer cells, and can potentially induce apoptosis at high levels [330], and conversely antioxidants may cause an increase in the risk…”
BackgroundMetabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2017) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 171
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Corbet, C., & Feron, O. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.002 · Cited by 172
Gal, K. L., Schmidt, E. E., & Sayin, V. I. (2021) · Antioxidants · doi:10.3390/antiox10091377 · Cited by 184
Self-citationReactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2606928 · Cited by 161
“Third, many studies have documented the role of antioxidant agents and Nrf2 activation in accelerating tumor metastasis; however, the related mechanisms remain unclear [119, 279, 280].”
The amoeboid state as part of the epithelial-to-mesenchymal transition programme
Graziani, V., Rodriguez-Hernandez, I., Maiques, O., & Sanz-Moreno, V. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.10.004 · Cited by 160
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
Harris, I. S., Endress, J. E., Coloff, J. L., Selfors, L. M., McBrayer, S. K., Rosenbluth, J. M., Takahashi, N., Dhakal, S., Koduri, V., Oser, M. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.020 · Cited by 170
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Kreuzaler, P., Panina, Y., Segal, J., & Yuneva, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.021 · Cited by 163
“Furthermore, it has been shown that the ability to cope with oxidative stress may be essential in some cancer types, since folate pathway inhibition decreases the metastatic potential of melanoma cells [205], and treatment with the antioxidant N-acetylcysteine conversely promotes melanoma metastasis [206].”
BackgroundMitochondria, cholesterol and cancer cell metabolism
Ribas, V., García‐Ruiz, C., & Fernández‐Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 159
“For instance, metastatic cells undergo reversible metabolic changes that allow them to counteract oxidative stress [156, 181].”
BackgroundTargeting Metabolic–Redox Circuits for Cancer Therapy
Wang, K., Jiang, J., Lei, Y., Zhou, S., Wei, Y., & Huang, C. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.001 · Cited by 162
Role of Reactive Oxygen Species in Aging and Age-Related Diseases: A Review
Anik, M. I., Mahmud, N., Masud, A. A., Khan, M. I., Islam, M. N., Uddin, S., & Hossain, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00411 · Cited by 172
NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells
Skonieczna, M., Hejmo, T., Poterała-Hejmo, A., Cieślar‐Pobuda, A., & Bułdak, R. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9420539 · Cited by 167
“More recently, researchers from Sweden have shown that even relatively low doses of antioxidants may enhance the growth of lung tumors and melanomas in mice [2, 3].”
BackgroundXing, Y., Wei, X., Liu, Y., Wang, M., Sui, Z., Wang, X., Zhu, W., Wu, M., Chen, L., Fei, Y.-H., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.2008752 · Cited by 164
The differential role of reactive oxygen species in early and late stages of cancer
Assi, M. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2017 · Cited by 158
“This is in line with our research and that of other laboratories, showing that vitamins C and E, NAC, and quercetin accelerated cancer progression, metastasis, and cachexia development in rodents, while inhibitors of thioredoxin and GSH induced tumor regression (2, 25, 36, 45, 57, 64) (Table 1).”
ResultRedox control in cancer development and progression
Helfinger, V., & Schröder, K. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.02.003 · Cited by 151
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
Estrela, J. M., Mena, S., Obrador, E., Benlloch, M., Castellano, G., Palmer, R. S., & Dellinger, R. W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01026 · Cited by 152
Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Chaiswing, L., St. Clair, W. H., & St. Clair, D. K. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7485 · Cited by 145
Circulating Tumor Cells: Moving Biological Insights into Detection
Chen, L., Bode, A. M., & Dong, Z. (2017) · Theranostics · doi:10.7150/thno.18588 · Cited by 150
“The association with platelets not only stimulates reversible metabolic changes in cancer cells that enable them to withstand oxidative stress [67, 70], but also links tumor cells with CD11b+ macrophages, establishing microclots to protect CTCs in the circulating blood [71].”
BackgroundRegulation of antioxidants in cancer
Hecht, F., Zocchi, M., Alimohammadi, F., & Harris, I. S. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.001 · Cited by 150
Lee, H., Li, C., Ruan, D., He, J., Montal, E. D., Lorenz, S., Girnun, G. D., & Chan, C. (2019) · Nature Communications · doi:10.1038/s41467-019-10374-y · Cited by 147
Transsulfuration, minor player or crucial for cysteine homeostasis in cancer
Zhang, H., Geltink, R. I. K., Parker, S. J., & Sorensen, P. H. B. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.02.009 · Cited by 148
Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination
Zheng, Y., Miyamoto, D. T., Wittner, B. S., Sullivan, J. P., Aceto, N., Jordan, N. V., Yu, M., Karabacak, M., Comaills, V., Morris, R. T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14344 · Cited by 148
Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications
Akter, S., Madhuvilakku, R., Kar, A. K., Nila, I. S., Liu, P., Inuzuka, H., Wei, W., & Hong, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02583-x · Cited by 168
Mitochondrial Calcium Regulation of Redox Signaling in Cancer
Delierneux, C., Kouba, S., Shanmughapriya, S., Potier‐Cartereau, M., Trebak, M., & Hempel, N. (2020) · Cells · doi:10.3390/cells9020432 · Cited by 146
“Similarly, in a mouse model of malignant melanoma, antioxidant treatment, including the use of N-acetyl-cysteine, a glutathione precursor, promoted metastasis and cell invasion [93].”
BackgroundThe GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells
Talwar, D., Miller, C. G., Grossmann, J., Szyrwiel, L., Schwecke, T., Demichev, V., Mikecin Drazic, A.-M., Mayakonda, A., Lutsik, P., Veith, C., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00781-3 · Cited by 132
Tian, S., Chu, Y., Hu, J., Ding, X., Liu, Z., Fu, D., Yuan, Y., Deng, Y., Wang, G., Wang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325137 · Cited by 137
Redox Regulation in Cancer Cells during Metastasis
Tasdogan, A., Ubellacker, J. M., & Morrison, S. J. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0558 · Cited by 136
“Treatment of mice with antioxidants increases the frequency of circulating cancer cells in the blood and metastatic disease burden (24, 30, 47, 58, 59).”
BackgroundAghapour, M., Remels, A. H. V., Pouwels, S. D., Bruder, D., Hiemstra, P. S., Cloonan, S. M., & Heijink, I. H. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00329.2019 · Cited by 133
Hatem, E., El Banna, N., & Huang, M.-E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 127
Maintenance of redox homeostasis by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.022 · Cited by 127
“For example, abrogating ROS-mediated signaling might reduce primary tumor growth, but mouse models of breast cancer and melanoma suggest that abrogating oxidative stress promotes metastasis [36,37].”
Backgroundvan Weverwijk, A., Koundouros, N., Iravani, M., Ashenden, M., Gao, Q., Poulogiannis, G., Jungwirth, U., & Isacke, C. M. (2019) · Nature Communications · doi:10.1038/s41467-019-10592-4 · Cited by 122
Metadata
- Authors
- Le Gal, K., Ibrahim, M. X., Wiel, C., Sayin, V. I., Akula, M. K., Karlsson, C., Dalin, M. G., Akyürek, L. M., Lindahl, P., Nilsson, J., & Bergo, M. O.
- Affiliations
- Sahlgrenska Cancer Center, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
- University of Gothenburg (SE)
- Corresponding author
- Dalin, Martin G.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2015-10-07
- Volume
- 7
- Issue
- 308
- Pages
- 308re8-308re8
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2142141154
- Cited by
- 632
- References
- 35
- Citations by year
- 2026: 22 · 2025: 49 · 2024: 49 · 2023: 53 · 2022: 65 · 2021: 68 · 2020: 76 · 2019: 77 · 2018: 51 · 2017: 66 · 2016: 47 · 2015: 8
- FWCI
- 24.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swedish Cancer Society
- Goran Gustafsson Foundation
- Ingabritt and Arne Lundberg's Research Foundation
- Knut and Alice Wallenberg Foundation
- Swedish Research Council
- Assar Gabrielsson Foundation
- Swedish Children's Cancer Fund
- BioCARE�a National Strategic Research Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- antioxidants, melanoma, N-acetylcysteine, Trolox, vitamin E, lymph node metastasis, tumor cell migration, tumor invasion, glutathione, RhoA signaling, glutathione synthesis, tumor progression, dietary supplements
- MeSH terms
- Acetylcysteine, Animals, Antioxidants, Chromans, Disease Models, Animal, Glutathione, Humans, Male, Melanoma, Neoplasm Metastasis, Dietary Supplements, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.